The startup develops proprietary medical devices for the treatment of chronic venous diseases, utilizing minimally invasive endovenous techniques that leverage the body's natural biological response. Their technology provides a pain-free alternative for patients suffering from varicose veins and venous ulcers, ensuring safe and effective treatment outcomes.
Funding
$5.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Chronic venous disease, affecting a significant portion of the adult population, leads to conditions like varicose veins and venous leg ulcers due to ineffective blood circulation. Current treatments often involve invasive procedures or methods that can damage surrounding tissue and may not address the underlying cause of the disease.
Solution
InVera Medical is developing a minimally invasive catheter system, the InVera Infusion Device, designed to treat chronic venous disease by delivering physician-specified agents, including sclerosants, directly to targeted veins in the peripheral vasculature. The device features a helical coil with a micro-textured lumen engaging outer surface that induces venospasm and disrupts the vessel wall, optimizing the environment for the infused agent to act on the target vessel wall. This approach aims to provide a less invasive, effective, and pain-free treatment option for patients suffering from varicose veins and venous ulcers. The InVera Infusion Device is designed to enhance procedural efficiency and patient comfort, potentially allowing more patients to access effective treatment for venous disease.
Target Audience
The primary target audience includes vascular surgeons and phlebologists treating patients with chronic venous disease, as well as outpatient centers and vein clinics in the US and EU.
Features
- Minimally invasive, single-use, disposable catheter system for vascular treatments
- Nitinol helical coil with micro-textured lumen engaging outer surface to disrupt the vein wall
- Delivery catheter to hold the constrained coil during navigation and deliver physician-specified agents
- Ergonomic pin and pull handle for easy deployment and recapture of the helical coil
- Integrated infusion port with a standard luer connector for seamless agent delivery
- Precise delivery engineered for targeted infusion of physician-specified agents to the vein lumen and sub-endothelial layers
- Intuitive method based on existing minimally invasive ultrasound-guided endovascular techniques
- Non-thermal, Non-Tumescent technique requiring only a single injection of local anesthetic